Sell-the-News Hits MoonLake: Strong Sonelokimab Data Fail to Impress vs. Bimzelx
Strong results matched but did not beat Bimzelx, triggering sell-the-news.
Already have an account? Sign in.
Strong results matched but did not beat Bimzelx, triggering sell-the-news.
Viewing rose 2% in H1 2026; Wells Fargo stays Underweight with a $57 target.
Wave plans a single two-year trial for WVE-006 in AATD after FDA feedback, with a one-year review for possible accelerated approval.
A federal judge dismissed Chegg and Penske antitrust suits over Google AI Overviews, saying expected search traffic is not a contract.